AMRX Insider Trading

Insider Ownership Percentage: 17.45%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $8,444,348.02

Amneal Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Amneal Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amneal Pharmaceuticals Share Price & Price History

Current Price: $11.83
Price Change: Price Decrease of -0.51 (-4.13%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for AMRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Amneal Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2025Ted C. NarkDirectorSell50,000$11.72$586,000.00291,029View SEC Filing Icon  
11/17/2025Ted C. NarkDirectorSell50,000$11.72$586,000.00291,029View SEC Filing Icon  
11/12/2025Nikita ShahEVPSell131,856$11.92$1,571,723.52146,403View SEC Filing Icon  
8/27/2025John KielyDirectorSell32,000$9.23$295,360.00225,433View SEC Filing Icon  
8/25/2025Nikita ShahEVPSell6,340$9.50$60,230.00146,403View SEC Filing Icon  
8/22/2025Nikita ShahEVPSell114,492$9.66$1,105,992.72152,743View SEC Filing Icon  
8/20/2025Andrew S. BoyerEVPSell279,244$9.38$2,619,308.72152,426View SEC Filing Icon  
8/14/2025Nikita ShahEVPSell71,694$9.29$666,037.26267,235View SEC Filing Icon  
8/12/2025Andrew S. BoyerEVPSell33,436$9.05$302,595.80256,670View SEC Filing Icon  
8/12/2025Jason B DalyEVPSell22,000$9.05$199,100.0010,606View SEC Filing Icon  
8/12/2025Nikita ShahEVPSell50,000$9.04$452,000.00338,929View SEC Filing Icon  
3/14/2025Tushar Bhikhubhai PatelMajor ShareholderSell5,000,000$8.35$41,750,000.0048,578,209View SEC Filing Icon  
3/3/2025Gautam PatelDirectorSell80,000$8.90$712,000.001,808,886View SEC Filing Icon  
2/3/2025Gautam PatelDirectorSell80,000$8.14$651,200.001,888,886View SEC Filing Icon  
1/8/2025Gautam PatelDirectorSell62,590$8.01$501,345.901,968,886View SEC Filing Icon  
1/2/2025Gautam PatelDirectorSell17,410$8.01$139,454.102,031,476View SEC Filing Icon  
11/15/2024Jason B DalySVPSell43,657$8.61$375,886.7713,665View SEC Filing Icon  
8/11/2023Andrew S. BoyerEVPSell29,302$4.13$121,017.26244,739View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Amneal Pharmaceuticals (NASDAQ:AMRX)

31.82% of Amneal Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AMRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Amneal Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Hsbc Holdings PLC101,945$1.30M0.0%+1.6%0.032%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.109,959$1.39M0.0%N/A0.035%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC13,828$0.17M0.0%N/A0.004%Search for SEC Filing on Google Icon
3/6/2026Hsbc Holdings PLC101,945$1.30M0.0%+1.6%0.032%Search for SEC Filing on Google Icon
2/26/2026Alpine Global Management LLC16,083$0.20M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/19/2026Mcguire Capital Advisors Inc.6,620$83K0.1%N/A0.002%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.1,750,718$22.06M0.0%+3.9%0.557%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC13,828$0.17M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV65,697$0.83M0.0%+528.4%0.021%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp181,806$2.34M0.0%-7.1%0.058%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd21,794$0.28M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/18/2026Zacks Investment Management48,625$0.61M0.0%-10.9%0.015%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC563,680$7.10M0.0%+139.4%0.179%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP64,161$0.81M0.0%-2.9%0.020%Search for SEC Filing on Google Icon
2/18/2026Tudor Investment Corp ET AL53,288$0.67M0.0%-42.1%0.017%Search for SEC Filing on Google Icon
2/18/2026Numerai GP LLC124,941$1.57M0.2%+7.8%0.040%Search for SEC Filing on Google Icon
2/18/2026Occudo Quantitative Strategies LP28,112$0.35M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/18/2026Odyssean LLC58,692$0.74M0.5%N/A0.019%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC3,360,198$42.34M0.0%+0.8%1.069%Search for SEC Filing on Google Icon
2/18/2026Man Group plc62,826$0.79M0.0%-81.4%0.020%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC76,216$0.96M0.0%+29.6%0.024%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP17,850$0.23M0.0%-80.2%0.006%Search for SEC Filing on Google Icon
2/18/2026Caption Management LLC81,735$1.03M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.689,867$8.69M0.0%+6.8%0.219%Search for SEC Filing on Google Icon
2/18/2026Bridgeway Capital Management LLC111,449$1.40M0.0%N/A0.035%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC1,046,112$13.18M0.0%+3.2%0.333%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC19,302$0.24M0.1%N/A0.006%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers21,445$0.27M0.0%+47.2%0.007%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC1,060,916$13.37M0.1%+88.9%0.337%Search for SEC Filing on Google Icon
2/17/2026Amundi45,463$0.57M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC236,395$2.98M0.0%-22.4%0.075%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD144,704$1.82M0.0%+5.1%0.046%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.389,357$4.93M0.0%-28.7%0.124%Search for SEC Filing on Google Icon
2/17/2026Kemnay Advisory Services Inc.2,060$26K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board168,490$2.12M0.0%+68.3%0.054%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP825,999$10.41M0.1%+11.2%0.263%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada9,455$0.12M0.0%-99.4%0.003%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.90,424$1.14M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/17/2026Magnetar Financial LLC10,202$0.13M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC168,633$2.13M0.0%-68.8%0.054%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC62,247$0.78M0.0%-50.1%0.020%Search for SEC Filing on Google Icon
2/16/2026MML Investors Services LLC82,434$1.04M0.0%+58.5%0.026%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC345,193$4.35M0.0%-12.6%0.110%Search for SEC Filing on Google Icon
2/16/2026Fieldview Capital Management LLC12,971$0.16M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC361,238$4.55M0.0%+4.8%0.115%Search for SEC Filing on Google Icon
2/16/2026Aigen Investment Management LP37,674$0.48M0.1%+268.2%0.012%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC10,045$0.13M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/13/2026Nantahala Capital Management LLC2,447,516$30.84M1.0%-42.1%0.779%Search for SEC Filing on Google Icon
2/13/2026Transamerica Financial Advisors LLC2,914$37K0.0%+541.9%0.001%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 79,660$1M0.0%-2.7%0.025%Search for SEC Filing on Google Icon
2/13/2026Segall Bryant & Hamill LLC391,771$4.94M0.1%-1.0%0.125%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp188,332$2.37M0.0%-1.0%0.060%Search for SEC Filing on Google Icon
2/13/2026Morgan Stanley4,818,099$60.71M0.0%+37.5%1.533%Search for SEC Filing on Google Icon
2/13/2026Essex Investment Management Co. LLC4,295$54K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC19,148$0.24M0.0%+24.0%0.006%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP640,284$8.07M0.0%+3.3%0.204%Search for SEC Filing on Google Icon
2/13/2026Headlands Technologies LLC61,725$0.78M0.1%+52.9%0.020%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.2,144,471$27.02M0.0%+3.0%0.682%Search for SEC Filing on Google Icon
2/13/2026State Street Corp4,110,410$51.79M0.0%+3.4%1.308%Search for SEC Filing on Google Icon
2/13/2026Ieq Capital LLC92,068$1.16M0.0%-4.9%0.029%Search for SEC Filing on Google Icon
2/13/2026Martingale Asset Management L P209,846$2.64M0.1%+4.8%0.067%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC243,133$3.06M0.0%+3.9%0.077%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN172,676$2.18M0.0%+80.0%0.055%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP144,642$1.82M0.0%N/A0.046%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC80,248$1.01M0.0%-9.9%0.026%Search for SEC Filing on Google Icon
2/12/2026State Board of Administration of Florida Retirement System61,768$0.78M0.0%+18.6%0.020%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC16,400$0.21M0.0%-81.8%0.005%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP5,609,040$70.68M0.0%+3.3%1.784%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.2,297$29K0.0%+1,680.6%0.001%Search for SEC Filing on Google Icon
2/12/2026Informed Momentum Co LLC425,718$5.36M0.6%N/A0.135%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund841,193$10.60M0.0%+281.3%0.268%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank309,600$3.90M0.0%+1.9%0.098%Search for SEC Filing on Google Icon
2/12/2026Aviva PLC25,078$0.32M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC3,221,721$40.59M0.0%-0.1%1.025%Search for SEC Filing on Google Icon
2/12/2026MIdWestOne Financial Group Inc.14,142$0.18M0.0%-8.8%0.004%Search for SEC Filing on Google Icon
2/11/2026Janney Montgomery Scott LLC30,627$0.39M0.0%+32.3%0.010%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG118,251$1.49M0.0%-87.6%0.038%Search for SEC Filing on Google Icon
2/11/2026Fox Run Management L.L.C.33,724$0.43M0.1%N/A0.011%Search for SEC Filing on Google Icon
2/11/2026Cerity Partners LLC14,443$0.18M0.0%+19.1%0.005%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC74,815$0.94M0.0%-12.4%0.024%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.414,540$5.22M0.0%+340.9%0.132%Search for SEC Filing on Google Icon
2/11/2026O Shaughnessy Asset Management LLC156,341$1.97M0.0%+5.3%0.050%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.662,647$8.35M0.0%-14.1%0.211%Search for SEC Filing on Google Icon
2/11/2026Los Angeles Capital Management LLC194,737$2.45M0.0%-15.5%0.062%Search for SEC Filing on Google Icon
2/11/2026Vestcor Inc10,532$0.13M0.0%-55.0%0.003%Search for SEC Filing on Google Icon
2/11/2026Vise Technologies Inc.10,155$0.13M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/11/2026Globeflex Capital L P136,505$1.72M0.3%+324.1%0.043%Search for SEC Filing on Google Icon
2/11/2026State of Wyoming43,590$0.55M0.1%-23.1%0.014%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.2,581,075$32.52M0.0%+4.9%0.821%Search for SEC Filing on Google Icon
2/10/2026BNP Paribas Financial Markets703,664$8.87M0.0%+107.7%0.224%Search for SEC Filing on Google Icon
2/10/2026Norges Bank889,500$11.21M0.0%N/A0.283%Search for SEC Filing on Google Icon
2/10/2026Hillsdale Investment Management Inc.714,529$9M0.2%-0.2%0.227%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC97,573$1.23M0.0%+1.2%0.031%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC3,986,554$50.24M0.0%-1.2%1.268%Search for SEC Filing on Google Icon
2/9/2026Penn Capital Management Company LLC1,001,951$12.66M1.0%N/A0.319%Search for SEC Filing on Google Icon
2/9/2026Jackson Creek Investment Advisors LLC222,133$2.80M0.8%-4.5%0.071%Search for SEC Filing on Google Icon
2/9/2026Jefferies Financial Group Inc.71,992$0.91M0.0%N/A0.023%Search for SEC Filing on Google Icon
2/6/2026Global Retirement Partners LLC9,145$0.12M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/6/2026Covestor Ltd9,618$0.12M0.1%+4,883.4%0.003%Search for SEC Filing on Google Icon
2/6/2026Handelsbanken Fonder AB53,900$0.68M0.0%+38.2%0.017%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Amneal Pharmaceuticals logo
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment offers immediate and extended release oral solid, powder, liquid, sterile injectable, nasal spray, inhalation and respiratory, biosimilar, ophthalmic, film, transdermal patch, and topical products. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson's disease, and endocrine disorders. This segment also provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid for the treatment of hypothyroidism; and IPX203, a pipeline product for Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
Read More on Amneal Pharmaceuticals

Today's Range

Now: $11.83
Low: $11.75
High: $12.43

50 Day Range

MA: $13.70
Low: $11.83
High: $15.19

52 Week Range

Now: $11.83
Low: $6.68
High: $15.42

Volume

5,614,529 shs

Average Volume

2,387,916 shs

Market Capitalization

$3.72 billion

P/E Ratio

51.44

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of Amneal Pharmaceuticals?

Amneal Pharmaceuticals' top insider shareholders include:
  1. Tushar Bhikhubhai Patel (Major Shareholder)
  2. Gautam Patel (Director)
  3. Nikita Shah (EVP)
  4. Ted C Nark (Director)
  5. Andrew S Boyer (EVP)
  6. John Kiely (Director)
  7. Jason B Daly (SVP)
  8. Jason B Daly (EVP)
Learn More about top insider investors at Amneal Pharmaceuticals.

Who are the major institutional investors of Amneal Pharmaceuticals?

Amneal Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 5.70%
  2. Dimensional Fund Advisors LP — 1.78%
  3. Morgan Stanley — 1.53%
  4. State Street Corp — 1.31%
  5. Geode Capital Management LLC — 1.27%
  6. Assenagon Asset Management S.A. — 1.20%
Learn More about top institutional investors of Amneal Pharmaceuticals stock.

Which major investors are selling Amneal Pharmaceuticals stock?

During the previous quarter, AMRX stock was sold by these institutional investors:
  1. Nantahala Capital Management LLC
  2. Royal Bank of Canada
  3. Deutsche Bank AG
  4. UBS Group AG
  5. Squarepoint Ops LLC
  6. Man Group plc
  7. Russell Investments Group Ltd.
  8. JPMorgan Chase & Co.
In the previous year, company insiders that have sold Amneal Pharmaceuticals company stock include:
  1. Tushar Bhikhubhai Patel (Major Shareholder)
  2. Gautam Patel (Director)
  3. Nikita Shah (EVP)
  4. Ted C Nark (Director)
  5. Andrew S Boyer (EVP)
Learn More investors selling Amneal Pharmaceuticals stock.

Which major investors are buying Amneal Pharmaceuticals stock?

Within the previous quarter, AMRX stock was purchased by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Morgan Stanley
  3. Penn Capital Management Company LLC
  4. Norges Bank
  5. SG Americas Securities LLC
  6. New York State Common Retirement Fund
  7. Jain Global LLC
  8. Informed Momentum Co LLC